Praxis Precision Medicines, Inc. (PRAX) Financial Statements (2024 and earlier)

Company Profile

Business Address 99 HIGH STREET, 30TH FLOOR
BOSTON, MA 02110
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:100,489275,900296,608
Cash and cash equivalents61,615138,704296,608
Short-term investments 38,874105,678 
Other undisclosed cash, cash equivalents, and short-term investments  31,518 
Other undisclosed current assets10,35111,5095,718
Total current assets:110,840287,409302,326
Noncurrent Assets
Operating lease, right-of-use asset2,9013,653754
Property, plant and equipment9711,21382
Other noncurrent assets41647215
Total noncurrent assets:4,2885,338851
TOTAL ASSETS:115,128292,747303,177
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30,52237,62414,957
Accounts payable14,67210,7804,088
Accrued liabilities15,85026,84410,869
Deferred revenue2,818  
Other undisclosed current liabilities1,005810763
Total current liabilities:34,34538,43415,720
Noncurrent Liabilities
Long-term debt and lease obligation:  3,501 
Liabilities, other than long-term debt4,677  
Deferred revenue2,182  
Operating lease, liability2,4953,501 
Other undisclosed noncurrent liabilities  (3,501) 
Total noncurrent liabilities:4,6773,501 
Total liabilities:39,02241,93515,720
Equity
Equity, attributable to parent76,106250,812287,457
Common stock554
Additional paid in capital606,918567,598437,007
Accumulated other comprehensive loss (173)(176) 
Accumulated deficit(530,644)(316,615)(149,554)
Total equity:76,106250,812287,457
TOTAL LIABILITIES AND EQUITY:115,128292,747303,177

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues
(Other undisclosed Revenues)
   
Gross profit:   
Operating expenses(214,986)(167,332)(61,968)
Operating loss:(214,986)(167,332)(61,968)
Nonoperating income957271140
Other nonoperating income   
Loss from continuing operations before income taxes:(214,029)(167,061)(61,828)
Income tax benefit   8
Loss from continuing operations:(214,029)(167,061)(61,820)
Loss before gain (loss) on sale of properties:(167,061)(61,820)
Net loss attributable to parent:(214,029)(167,061)(61,820)
Other undisclosed net loss available to common stockholders, basic   (8,503)
Net loss available to common stockholders, diluted:(214,029)(167,061)(70,323)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(214,029)(167,061)(61,820)
Comprehensive loss:(214,029)(167,061)(61,820)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3(176) 
Comprehensive loss, net of tax, attributable to parent:(214,026)(167,237)(61,820)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: